Work is changing.
We’ll help you keep up.

Subscribe for our latest content.

Latest posts in

Tips and Information

Semaglutide vs. Tirzepatide: Key Differences ExplainedSemaglutide vs. Tirzepatide: Key Differences Explained
Semaglutide vs. tirzepatide: An honest side-by-side comparison

Comparing semaglutide versus tirzepatide? Here’s a clear look at weight loss results, side effects, and cardiovascular outcomes from head-to-head trials.

Wegovy® and Estrogen: How They Work Together in MenopauseWegovy® and Estrogen: How They Work Together in Menopause
Wegovy® and estrogen: Combining GLP-1s with hormone therapy

Wondering about Wegovy® and estrogen? See what research says about combining GLP-1s with HRT during menopause, and learn what to ask your doctor.

HRT and Postmenopause Ongoing Use: Safety and CareHRT and Postmenopause Ongoing Use: Safety and Care
HRT and postmenopause ongoing use: Understanding benefits and risks

Navigating HRT and postmenopause ongoing use? Learn the real benefits and risks of long-term hormone therapy and how Maven Clinic can help you decide.

HRT vs. Nonhormonal Treatments for Menopause Relief
HRT vs. Nonhormonal Treatments for Menopause Relief

Compare HRT versus nonhormonal treatments for menopause relief. Learn how each option works, what the benefits are, and how to choose the right path.

GLP-1s and Breastfeeding: Safety Considerations to Know
GLP-1s and Breastfeeding: Safety Considerations to Know

Explore GLP-1s and breastfeeding safety considerations. Learn about the risks, safe alternatives, and how Maven Clinic can help with your postpartum goals.

Orforglipron vs. Semaglutide: Comparing the Two Glp-1 Ras
Orforglipron vs. Semaglutide: Comparing the Two Glp-1 Ras

Foundayo® (orforglipron) is the newest FDA-approved GLP-1 pill. Compare orforglipron versus semaglutide, from approved indications to side effect risk.

Curious what Maven
can do for you?